{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:18:29Z","timestamp":1792790309765,"version":"4.5.0"},"posted":{"date-parts":[[2026,9,11]]},"group-title":"Genetic and Genomic Medicine","reference-count":26,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"award":["R01NS140459, U01NS106513, RF1NS139183, R01EB03650"],"award-info":[{"award-number":["R01NS140459, U01NS106513, RF1NS139183, R01EB03650"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"name":"American Heart Association","award":["817874, 24GWTGSIC1341098, 23BFHSCP1178409"],"award-info":[{"award-number":["817874, 24GWTGSIC1341098, 23BFHSCP1178409"]}],"id":[{"id":"https:\/\/ror.org\/013kjyp64","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Yale Claude D. Pepper Older Americans Independence Center","award":["P30AG021342"],"award-info":[{"award-number":["P30AG021342"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,9,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To determine whether a multi-trait polygenic profile for dementia is associated with dementia- and disability-free survival in middle-aged and older adults.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Clinical trials of brain health and aging increasingly use holistic, patient-centered outcomes that capture overall health status. Survival free of dementia and disability is one such outcome. We hypothesized that adverse polygenic profiles for dementia would be associated with higher risk of dementia, disability, or death.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Design\/Methods<\/jats:title>\n                  <jats:p>We conducted a genetic association study within the Health and Retirement Study, a prospective, nationally representative longitudinal cohort of U.S. adults. Polygenic profiling used the previously validated integrated polygenic risk score for dementia (iPRS-DEM), which incorporates neurodegenerative and vascular genetic components. Participants were categorized as having favorable (\u226420th percentile), intermediate (20th-80th percentile), or poor (&gt;80th percentile) polygenic profiles. The primary outcome was a composite of dementia, disability, or death. Cox proportional hazards models were adjusted for age, sex, genetic ancestry, and genetic principal components. Interaction between continuous iPRS-DEM and APOE \u03b54 status was assessed for 31-year outcome risk.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 45,234 HRS participants, 15,620 provided DNA samples, 15,565 had genotype data after quality control and imputation, and 14,333 were free of dementia and disability at baseline (median age 55 years; 58% female). Compared with a favorable polygenic profile, intermediate and poor profiles were associated with higher risk of the composite outcome (HR 1.14, 95% CI 1.07-1.21 and HR 1.43, 95% CI 1.26-1.63, respectively). The relative association was strongest for dementia; for poor versus favorable profiles, HRs were 1.58 (95% CI 1.21-2.05) for dementia, 1.43 (95% CI 1.14-1.79) for disability, and 1.33 (95% CI 1.15-1.54) for death. An interaction between continuous iPRS-DEM and APOE \u03b54 status was observed for 31-year dementia risk (P=0.016). Relative to favorable-profile APOE \u03b54 non-carriers, dementia risk was highest among participants with a poor profile who were APOE \u03b54 carriers (HR 2.32, 95% CI 1.73-3.12).<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Adverse polygenic profiles for dementia were associated with higher composite risk of dementia, disability, or death in a large population-based cohort, with the strongest association observed for dementia. Joint consideration of iPRS-DEM and APOE \u03b54 further identified individuals at elevated dementia risk. These findings support the potential value of polygenic profiling for risk stratification while highlighting limitations related to ancestry, generalizability, and clinical translation.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.09.09.26362686","type":"posted-content","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:40:11Z","timestamp":1789184411000},"source":"Crossref","is-referenced-by-count":0,"title":["Multi-trait Polygenic Profiling and Survival Free of Dementia and Disability: Results from the Health and Retirement Study"],"prefix":"10.64898","author":[{"given":"Yome","family":"Tawaldemedhen","sequence":"first","affiliation":[{"name":"Department of Neurology, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Clocchiatti-Tuozzo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yale School of Medicine, New Haven, CT, USA"},{"name":"Yale Center for Brain and Mind Health, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyprien","family":"Rivier","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yale School of Medicine, New Haven, CT, USA"},{"name":"Yale Center for Brain and Mind Health, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufan","family":"Huo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yale School of Medicine, New Haven, CT, USA"},{"name":"Yale Center for Brain and Mind Health, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Silberfeld","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"D\u2019Aoust","sequence":"additional","affiliation":[{"name":"Bordeaux Population Health Center, INSERM, UMR U1219, University of Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Debette","sequence":"additional","affiliation":[{"name":"Bordeaux Population Health Center, INSERM, UMR U1219, University of Bordeaux, Bordeaux, France"},{"name":"Department of Neurology, Institute for Neurodegenerative Diseases, CHU de Bordeaux, Bordeaux, France"},{"name":"Institut du Cerveau (ICM), Paris Brain Institute, INSERM U1127, UMR CNRS 7225, Sorbonne Universit\u00e9, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"de Havenon","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yale School of Medicine, New Haven, CT, USA"},{"name":"Yale Center for Brain and Mind Health, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Gill","sequence":"additional","affiliation":[{"name":"Division of Geriatric Medicine, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6407-0302","authenticated-orcid":false,"given":"Guido J.","family":"Falcone","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yale School of Medicine, New Haven, CT, USA"},{"name":"Yale Center for Brain and Mind Health, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026091507250552000_2026.09.09.26362686v1.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1800722"},{"key":"2026091507250552000_2026.09.09.26362686v1.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-069915"},{"key":"2026091507250552000_2026.09.09.26362686v1.3","unstructured":"Duke University. PRagmatic EValuation of evENTs And Benefits of Lipid-Lowering in oldEr Adults (PREVENTABLE). ClinicalTrials.gov; 2026. Accessed July 16, 2026. https:\/\/clinicaltrials.gov\/study\/NCT04262206"},{"key":"2026091507250552000_2026.09.09.26362686v1.4","doi-asserted-by":"publisher","DOI":"10.1038\/ng0694-180"},{"key":"2026091507250552000_2026.09.09.26362686v1.5","doi-asserted-by":"publisher","DOI":"10.1126\/science.8346443"},{"key":"2026091507250552000_2026.09.09.26362686v1.6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.11.1300"},{"key":"2026091507250552000_2026.09.09.26362686v1.7","doi-asserted-by":"publisher","DOI":"10.1086\/301849"},{"key":"2026091507250552000_2026.09.09.26362686v1.8","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.19043"},{"key":"2026091507250552000_2026.09.09.26362686v1.9","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70014"},{"key":"2026091507250552000_2026.09.09.26362686v1.10","unstructured":"Theoretical and empirical quantification of the accuracy of polygenic scores in ancestry divergent populations. Nat Commun. Accessed July 16, 2026. https:\/\/www.nature.com\/articles\/s41467-020-17719-y"},{"key":"2026091507250552000_2026.09.09.26362686v1.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11112-0"},{"key":"2026091507250552000_2026.09.09.26362686v1.12","unstructured":"Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet. Accessed July 16, 2026. https:\/\/www.nature.com\/articles\/s41588-019-0379-x"},{"key":"2026091507250552000_2026.09.09.26362686v1.13","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyu067"},{"key":"2026091507250552000_2026.09.09.26362686v1.14","unstructured":"RAND HRS Longitudinal File 2022 (V1). Produced by the RAND Center for the Study of Aging, with funding from the National Institute on Aging and the Social Security Administration. Santa Monica, CA (May 2025)."},{"key":"2026091507250552000_2026.09.09.26362686v1.15","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bts479"},{"key":"2026091507250552000_2026.09.09.26362686v1.16","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.1785"},{"key":"2026091507250552000_2026.09.09.26362686v1.17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000529"},{"key":"2026091507250552000_2026.09.09.26362686v1.18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002258"},{"key":"2026091507250552000_2026.09.09.26362686v1.19","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv268"},{"key":"2026091507250552000_2026.09.09.26362686v1.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24082-z"},{"key":"2026091507250552000_2026.09.09.26362686v1.21","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-0764-y"},{"key":"2026091507250552000_2026.09.09.26362686v1.22","unstructured":"Alzheimer\u2019s disease polygenic risk\u2019s association with all-cause dementia through the plasma metabolome in the UK Biobank study. GeroScience. Accessed July 16, 2026. https:\/\/link.springer.com\/article\/10.1007\/s11357-025-01724-4"},{"key":"2026091507250552000_2026.09.09.26362686v1.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11558-2"},{"key":"2026091507250552000_2026.09.09.26362686v1.24","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.39856"},{"key":"2026091507250552000_2026.09.09.26362686v1.25","doi-asserted-by":"publisher","DOI":"10.1186\/s13742-015-0047-8"},{"key":"2026091507250552000_2026.09.09.26362686v1.26","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; Vienna, Austria. https:\/\/www.R-project.org\/"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.09.09.26362686","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T14:27:25Z","timestamp":1789482445000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.09.09.26362686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":26,"URL":"https:\/\/doi.org\/10.64898\/2026.09.09.26362686","relation":{},"subject":[],"published":{"date-parts":[[2026,9,11]]},"subtype":"preprint"}}